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The advent of optogenetics and genetically encoded photosensors has provided neu-
roscience researchers with a wealth of new tools and methods for examining and
manipulating neuronal function in vivo. There exists now a wide range of experimentally
validated protein tools capable of modifying cellular function, including light-gated ion
channels, recombinant light-gated G protein-coupled receptors, and even neurotransmitter
receptors modiﬁed with tethered photo-switchable ligands. A large number of genetically
encoded protein sensors have also been developed to optically track cellular activity in real
time, including membrane-voltage-sensitive ﬂuorophores and ﬂuorescent calcium and pH
indicators. The development of techniques for controlled expression of these proteins has
also increased their utility by allowing the study of speciﬁc populations of cells. Additionally,
recent advances in optics technology have enabled both activation and observation of
target proteins with high spatiotemporal ﬁdelity. In combination, these methods have great
potential in the study of neural circuits and networks, behavior, animal models of disease,
as well as in high-throughput ex vivo studies.This review collects some of these new tools
and methods and surveys several current and future applications of the evolving ﬁeld of
optophysiology.
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BACKGROUND
INTRODUCTION
Experiments using voltage-sensitive chemicals to optically mon-
itor activity in neurons have been evolving for several decades
(Woolum and Strumwasser, 1978). In recent years, there has been
a dramatic increase in the use of genetically encoded proteins
to visualize neuronal activity in vivo (Akerboom et al., 2012; Jin
et al., 2012). In addition, the ﬁeld of optogenetics, which uses
genetically encoded proteins for optical control of cellular func-
tions, is growing rapidly (Fenno et al., 2011). While there are also
many photo-responsive chemicals used in optophysiology, here
we will primarily review the use of genetically encoded proteins.
Discussion will encompass proteins with activity-sensitive ﬂuo-
rescence or luminescence (photosensors), optogenetic proteins
(photoactuators), methods for both optical manipulation and
measurement of these photo-sensitive proteins, and the applica-
tion of these proteins in physiologically relevant research. Thus,
this review will discuss optophysiology as a ﬁeld that includes
engineered proteins, the molecular biology components for their
expression, and the equipment, and software necessary for their
use in neuroscience. Finally, wewill review several successful appli-
cations of optophysiology for clinically relevant researchon animal
models of disease and high-throughput ex vivo drug screens.
OPTOPHYSIOLOGY MOVING FORWARD
Traditionally, examining the spatiotemporal characteristics of
neuronal activity has been accomplished using electrophysiolog-
ical techniques. Electrophysiology is the prevalent approach to
measuring and manipulating neuronal activity in experiments
such as cellular stimulation combined with ﬁeld recordings for
functional analysis of speciﬁc brain regions (Salah and Perkins,
2011), inducing long-term potentiation and depression of neu-
ronal activity (Pavlowsky and Alarcon, 2012), and observing
sensory encoding of physiologically relevant stimuli (Trapani et al.,
2009). Electrophysiological experiments can combine data from
multiple electrodes (Xu et al., 2012), can integrate electrodes into
a neuronal culture to facilitate prolonged measurements (Regehr
et al., 1989), and can even combine simultaneous electrophysiol-
ogy with optophysiology (Bender and Trussell, 2009). These cre-
ative techniques highlight the power of modern electrophysiology.
There are some limitations inherent in electrical stimulation
and recording with standard electrophysiological techniques. For
instance, it is difﬁcult to control an entire neuron’s membrane
potential fromonepoint of injected current (Spruston et al., 1993).
Furthermore, the placement of the electrode determines the neu-
ron to be examined, often making it technically challenging to
control a population or subset of speciﬁc neurons. This limitation
often precludes the number and type of experiments that can be
performed in vivo. In contrast, by exploiting genetics, optophys-
iology can target speciﬁc cells or tissues to achieve control of an
individual cell or a population of cells in vivo. In addition, the pro-
teins used for optophysiology are frequently tagged with a marker
to track the location of expression within a cell or brain region.
Thus, the nature of genetically encoded optical probes and actua-
tors allows for spatiotemporal control of expression across cellular
populations and canbe furthermanaged throughoptically focused
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activation. Furthermore, optophysiology has the ability to survey
large brain regions in real time with minimal disruption to the
organism (Ackman et al., 2012).
There are also important points for consideration of opto-
physiology. First, optimizing the action spectra and kinetics of
proteins for speciﬁc applications may require screening for use-
ful mutations or creating recombinant isoforms (Gunaydin et al.,
2010; Akerboom et al., 2012, 2013). Similarly, achieving appro-
priate expression patterns and subcellular location can be labor
intensive and expensive. Also, high levels of transgenic protein
may impair cellular function over time even with appropriately
controlled protein localization (Miyashita et al., 2013). Next, the
reliance on light necessitates the optical accessibility of the tissue
and cells being studies. Finally, optophysiology requires special-
ized optics and imaging technology for collection and analysis of
small, fast signals – ideally with low background noise.
OPTOPHYSIOLOGY TOOLS
PHOTOSENSORS
The key principal of an optical sensor is that it exhibits a change in
ﬂuorescence or luminescence following a conformational response
to changes in its chemical, mechanical, or electrical environment,
thus providing an optical report of this change (for a list of pop-
ular genetically encoded photosensors see Table 1). For example,
detection parameters can include the concentration of a ligand
of interest, the pH of the intracellular or extracellular environ-
ment, or neurotransmitter vesicle secretion (Miesenböck et al.,
1998). As is true for photoactuators (discussed below), an ideal
photosensor should be highly sensitive to the cellular function
of interest and speciﬁc enough to minimize background, non-
speciﬁc ﬂuorescence. The sensor should also beminimally invasive
and not disrupt normal cellular function. In most cases, it is
desirable to maximize the speed of a sensor’s response cycle so
that fast cellular activity may be visualized. Fluorescent photo-
sensors ought to be speciﬁcally sensitive at their peak excitation
wavelength, which may be optimized for spectral separation
from other photosensitive proteins that could be concomitantly
expressed (Akerboom et al., 2013).
Many ﬂuorescent photosensors rely on a single ﬂuorophore,
while others have a pair of ﬂuorophores that exhibit Förster res-
onance energy transfer (FRET) upon activation of one of the
molecules by a photon of a particularwavelength (or twoof double
Table 1 | Selected examples of genetically encoded photosensors.
Sensor Protein components Peak excitation
wavelength (nm)
Parameter
measured
Function reported Reference
GCaMP,
GCaMP5,
GCaMP7
M13, cpEGFP, CaM 489 Calcium Ca2+ concentration (e.g.,
intracellular stores or VGCCs)
Nakai et al. (2001); Pologruto et al. (2004),
Akerboom et al. (2012); Muto et al. (2013)
Cameleon M13, ECFP, EYFP, CaM 440 ECFP Calcium Ca2+ concentration (e.g.,
intracellular stores or VGCCs)
Truong et al. (2001, 2007)
Clomeleon,
Cl− Sensor
CFP,TFP 440 CFP Chloride Cl− concentration (e.g., via GABA
receptors)
Kuner and Augustine (2000)
Markova et al. (2008)
ArcLight ciVSP, super ecliptic
pHluorin
490 Voltage Action potentials,
neurotransmission-mediated ion
channel activity
Jin et al. (2012)
ElectricPk ciVSP, cpEGFP 488 Voltage Action potentials,
neurotransmission-mediated ion
channel activity
Barnett et al. (2012)
Arch Archaerhodopsin,
EGFP
640 (arch), 488
(GFP)
Voltage Action potentials,
neurotransmission-mediated ion
channel activity
Kralj et al. (2012)
pHlourin GFP 470 pH Vesicle fusion using
synapto-pHlourin
Miesenböck et al. (1998)
Bowser and Khakh (2007)
SuperGluSnFr GltI, ECFP, Citrine 476 CFP Glutamate Glutamate concentration (e.g.,
neurotransmitter release)
Hires et al. (2008)
Aequorin Apoaequorin,
coelenterate luciferin
n/a; luminescent Calcium Ca2+ concentration (e.g.,
intracellular stores or VGCCs)
Prasher et al. (1985)
A sample of popular genetically encoded protein photosensors. M13, M13 domain from myosin light chain kinase; cpEGFP, circularly permuted enhanced GFP; CaM,
Calmodulin; ciVSP, C. intestinalis voltage-sensitive phosphatase; VAMP2, vesicle-associated membrane protein 2; pHlourin, mutant, pH-sensitive GFP; GltI, glutamate
periplasmic binding protein; ECFP, enhanced cyan ﬂuorescent protein; FRET, Förster resonance energy transfer.
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the wavelength in the case of two-photon excitation). For single
ﬂuorescent molecules, the efﬁciency of ﬂuorescence provides a
readout of changes in the ﬂuorophore’s local environment. For
FRET pairs, changes in the chemical environment affect the efﬁ-
ciency of energy transfer between the two ﬂuorophores, which is
then measured as a change in the ratio of their individual ﬂuo-
rescences. This ratiometric imaging is beneﬁcial because it relies
on changes in relative ﬂuorescence and not absolute ﬂuorescence
levels. Since background noise such as non-speciﬁc autoﬂuo-
rescence may not affect FRET, ratiometric imaging may be less
problematic and data can often be more easily compared across
different experiments (Tadross et al., 2009; Kindt et al., 2012).
In addition to genetically encoded sensors, there are also pho-
toresponsive chemicals (e.g., Fura-2) that are used in optophy-
siology due to their favorable response characteristics (Dawitz
et al., 2011).
Many cellular properties may serve as functional indicators
of activity, two of which are membrane potential and intracel-
lular calcium concentration. In the past, the limited availability
of voltage-sensitive proteins that exhibit fast, large-magnitude
changes in photochemical properties (within the narrow∼100mV
range of an active neuron’s membrane potential) made calcium-
sensitive probes a more frequent choice for monitoring cellular
activity. Changes in intracellular calcium concentration have a
clear relevance to synaptic function and serve as an indica-
tor for pre- and post-synaptic neuronal activity. As a result of
the functional link between changes in calcium concentration
and neuronal activation, genetically encoded calcium indicators
(GECIs) are a popular choice for optically monitoring neuronal
activity. Such measurements can be performed at both the single
cell and whole-brain levels (Ackman et al., 2012; Akerboom et al.,
2012).
Researchers seeking calcium-responsive proteins for optical
probe design have exploited the key role of calcium in signaling
cascades. For example, the calcium-binding messenger protein,
calmodulin (CaM) has been used to create a chimeric GECI called
GCaMP. The GCaMP molecule comprises a circularly permuted
green ﬂuorescent protein (GFP) bound to both the calcium bind-
ing domain of calmodulin and the calmodulin-binding domain of
a myosin light chain kinase (M13; Nakai et al., 2001). The fusion
protein exhibits efﬁcient ﬂuorescence when calcium is bound,
whereas its ﬂuorescence decreases sharply when calcium is not
bound. GCaMP has been successfully used to visualize increases in
intracellular calciumconcentration that result from inﬂux through
voltage-gated calcium channels and/or calcium permeable recep-
tors, or release from intracellular stores. Efforts to improve the
GCaMP probe are ongoing. Mutant forms have been developed
with increased signal to noise ratios such as GCaMP5 (Akerboom
et al., 2012), and one of the latest iterations, GCaMP7, is both fast
and sensitive enough to monitor neuronal activity of the zebraﬁsh
optic tectum in real time (Muto et al., 2013).
Ratiometric indicators may be favorable when noisy data is
expected, since background activity may have a similar impact
on the detection of each ﬂuorophore in the pair. For example,
Cameleon is a chimeric, ratiometric calcium indicator, with the
same calmodulin and M13 domains as GCaMP and a pair of
ﬂuorophores that exhibit FRET. Upon calcium binding, there
is an increase in FRET efﬁciency, which provides a ratiomet-
ric measure of calcium changes (Truong et al., 2001, 2007).
Aequorin is an example of a calcium-sensitive luminescent pro-
tein; it emits a blue photon upon binding of calcium (Dugué
et al., 2012). This molecule avoids the potentially deleterious
effects of photo-excitation. However, since this molecule is lumi-
nescent rather than ﬂuorescent, emission intensity cannot be
directly increased through greater intensity of photo-stimula-
tion.
Similary, a ratiometric indicator of chloride concentration also
exists (Clomeleon; Kuner and Augustine, 2000) and was recently
improved to increase its chloride sensitivity into the physiologi-
cal range (Cl-Sensor; Markova et al., 2008). A very recent study
by Batti et al. used this ratiometric probe to generate Cl-Sensor
transgenic mice (Batti et al., 2013). In this study, the authors use
electrophysiology to calibrate chloride-dependent ﬂuorescence
changes to the intracellular chloride concentration in both hip-
pocampal and cortical neurons in brain slices. They further show
that non-invasivemonitoring of Cl-Sensor ﬂuorescence can report
the changes in intracellular chloride that occur during epilepti-
form activity (Dzhala and Staley, 2003; Ben-Ari et al., 2012). This
study provides a ﬁne example of how electrophysiology and opto-
physiology can be used concurrently to complement and validate
each other.
Voltage probes were originally more difﬁcult to use in part
because early examples tended to show a small ﬂuorescence
response across the physiological range of membrane potential
(Barnett et al., 2012; Mutoh et al., 2011). Voltage sensors couple
themovement of a dipole in themembrane to the conformation of
a ﬂuorophore or FRET pair to produce a detectable change in ﬂu-
orescence. Ideally, the sensitivity and speed of ﬂuorescence change
would allow the researcher to track the time course of actionpoten-
tials and other transient ionic currents that change the membrane
potential. Voltage sensitive proteins (VSPs) have several potential
advantages over calciumphotosensors. Since they do not sequester
calcium, these sensors may be less likely to disrupt in vivo activity
compared to a calcium-binding probe (Ouanounou et al., 1999).
In theory, voltage sensors can also detect non-calcium-dependent
sub-threshold activity and activity at gap junctionswhere neuronal
activity may not involve calcium (Perron et al., 2012). This fea-
ture allows researchers to better examine integration of neuronal
synaptic inputs. As voltage probes also show activity through-
out the cell rather than at regions of localized calcium inﬂux or
release from intracellular stores, they may produce a signal that
more faithfully follows the activity of the neuron. An example of
this is seen with voltage-sensitive chemicals, which were used to
track the initiation and movement of an action potential along
an axon (Foust et al., 2010). A current genetically encoded volt-
age sensor with great potential is Archaerhodopsin-3 (Arch). This
prominent voltage indicator protein is derived originally from a
microbial proton pump. Modiﬁcations made to the protein by
the Cohen lab have inactivated the proton pump, but maintained
its favorable voltage response characteristics and kinetics (Kralj
et al., 2012). Another ﬂuorescent voltage sensor called ArcLight
was recently developed, and since its ﬂuorescence arises from a
very different ﬂuorophore, it has a distinct set of properties as
compared to Arch (Jin et al., 2012).
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PHOTOACTUATORS
In early experiments on photo-activation of neurons, a genetic
component allowed for cell-type speciﬁcity, but exogenously
applied photoactuator chemicals were required to elicit responses
(Zemelman et al., 2003). This external chemical modiﬁcation
limited early approaches to in vitro experimentation and often
constrained experiments due to the toxicity or functional lifes-
pan of the organic chemical. Ideally, a genetically encoded protein
could servemanyof the same functions as systems requiring exoge-
nous actuators while avoiding many of their limitations. The ﬁrst
“optogenetic” photoactuator to satisfy these criteria came in the
form of a light-gated proton channel, channelrhodopsin (ChR1),
isolated from the photosynthetic algae C. reinhardtii (Nagel et al.,
2002). Subsequent modiﬁcation of channelrhodopsin created
channelrhodopsin-2 (ChR2) with a peak excitation wavelength of
470 nm, and increased conductance to cations that allows for the
depolarization of cells upon photo-activation (Nagel et al., 2003).
Initial experiments revealed that physiologically relevant non-
invasive activation of hippocampal neurons could be achieved
through ChR2 expression (Boyden et al., 2005). More recently,
mutagenesis screens and knowledge-guided structural mutations
have led to many variants of the channel that differ in ion conduc-
tance, response spectrum and response kinetics (Akerboom et al.,
2012; Rein and Deussing, 2012; Muto et al., 2013).
To make more use of the speciﬁcity of gene targeting, one of
the common goals of developing new optogenetic photo-actuator
proteins is to modify the function of an existing photoactuator
to perform a very specialized function. For most applications, the
ideal photoactuator is highly sensitive so that stimulation intensity
may be minimized and a controlled response will be observed with
minimal disruption to cellular function. Additionally, photoactua-
tors are often optimized in their kinetics or activation spectrum for
a given experiment. For instance, available photoactuators include
those capable of high-frequency signal transduction (Gunaydin
et al., 2010) or toggle-switch activity where the actuator can be
turned on and off (Berndt et al., 2009), and current efforts at
spectral modiﬁcation are focusing on proteins that are spectrally
divergent from other optogenetic tools to allow for combined
expression with minimal overlap of activation wavelength (Zhang
et al., 2008). In the next few paragraphs, we will discuss some of
these newly developed or modiﬁed optogenetic actuators.
Several groups have developed channelrhodopsin variants that
circumvent speciﬁc limiting characteristics of ChR2. Gunaydin
et al. (2010) introduced two point mutations in the channel that
allow for photostimulation up to a frequency of 200 Hz while also
increasing the response ﬁdelity of the protein. Thesemodiﬁcations
make for a protein with much better temporal precision, per-
mitting experiments probing the importance of high-frequency
bands such as gamma activity (Gunaydin et al., 2010). Berndt
et al. (2009) also found two point mutations in the original
ChR2 sequence that dramatically increase the time constant for
channel closing, leading to a more stable open-state after photo-
stimulation. Importantly, the researchers were able to achieve
de-activation through green light stimulation, resulting in a chan-
nel that can be photo-toggled on and off (Berndt et al., 2009).
Since multi-component systems tend to exhibit spectral overlap
between proteins, the stable “on” state of this actuator provides
an appealing way to minimize noise from non-speciﬁc inputs.
Zhang et al. (2008) describe a channelrhodopsin protein derived
from V. carteri, VChR1, with an activation spectrum peak that
is red-shifted by about 70 nm as compared to that of ChR2.
This spectral separation provides the possibility for simultaneous,
independent control of multiple cell types by photostimulation at
different wavelengths (Zhang et al., 2008). A wide range of addi-
tional combinations between various ChR2 mutants have been
explored to optimize a photoactuator for a given experimental
setup (Yizhar et al., 2011). The success of these efforts to modify
the properties of channelrhodopsin demonstrates the potential for
protein engineering to produce photoactuators precisely suited for
an application of interest.
A wide variety of other light-gated ion channels and pumps
have also been developed or isolated (see Table 2). N. pharao-
nis halorhodopsin (NpHR), a chloride ion pump activated by
570 nm light, provides the crucial inhibitory counterpart to
the stimulatory channelrhodopsin (Zhang et al., 2007). Similar
to channelrhodopsin, NpHR has been improved by molecu-
lar engineering, especially to improve its subcellular localization
(eNpHR3.0; Gradinaru et al., 2008). Proton pumps like bacteri-
orhodopsin can achieve a similar inhibitory effect (Dugué et al.,
2012). These recombinant photoactuators provide control of
neuronal membrane potential, but there are also many exper-
imentally interesting optogenetic targets in cellular metabolism
and metabotropic activity.
So-called“optoXRs,” chimeric or recombinant photo-inducible
G protein-coupled receptors, allow intervention in metabotropic
signaling pathways. As in other areas of the optogenetic ﬁeld,
optoXR design has progressed rapidly. Miesenböck and colleagues
formulated a system called “chARGe” in 2002 that requires trans-
fection of Drosophila Arrestin-2, rhodopsin, and the appropriate
G-protein (Zemelman et al., 2002). Subsequently, Deisseroth and
colleagues designed a simpler optoXR composed of a single-
component chimeric receptor from a bovine rhodopsin and
the intracellular G-protein-interacting domains of an adrenergic
receptor (see Table 2; Airan et al., 2009).
Another source of optogenetic actuators takes advantage of
native, ligand-gated receptors. Clever engineering can allow a
receptor to be photosensitive while also retaining its native lig-
and sensitivity. An example of this technique is seen in the
ionotropic glutamate receptor, which was modiﬁed with a photo-
switchable, tethered ligand allowing for light-activation of the
resulting photoactuator (LiGluR; Volgraf et al., 2006). Many suc-
cessful experiments with LiGluR have been done using zebraﬁsh,
where its transgenic expression has been used to study motor
circuits and behavior (reviewed in Simmich et al., 2012).
OVERVIEW OF TRANSGENIC STRATEGIES
The list of photosensors and photoactuators with new and inter-
esting properties continues to grow, as do the techniques for
effective transgene delivery. Due to their relative cost effectiveness
and simplicity, the use of viral vectors, such as adeno-associated
viral (AAV) vectors and lentiviral vectors for transgene delivery
is quite common (Cooray et al., 2012). Expression can be con-
trolled through copy number or the use of speciﬁc promoters and
enhancers. Some cell speciﬁcity can be achieved by selecting a virus
Frontiers in Molecular Neuroscience www.frontiersin.org July 2013 | Volume 6 | Article 18 | 4
“fnmol-06-00018” — 2013/7/16 — 9:51 — page 5 — #5
Smedemark-Margulies andTrapani Methods in neuroscience optophysiology
Table 2 | Selected examples of optogenetic photoactuators.
Photoactuator Source organism Peak excitation
wavelength (nm)
Parameter affected Functional purpose in neurons Reference
Step function
opsins
C. reinhardtii 470 on, 530 off Cation conductance Toggle of Vm Berndt et al. (2009)
VChR1 V. carteri 589 Cation conductance Depolarization of Vm Zhang et al. (2008)
Bacteriorhodopsin Halobacteria 568 Proton pumping Hyperpolarization of Vm Nishikawa et al. (2005)
ChR2 (channel-
rhodopsin)
C. reinhardtii 470 Cation conductance Depolarization of Vm Nagel et al. (2003)
ChETA C. reinhardtii 470 Cation conductance High frequency depolarization Gunaydin et al. (2010)
LiGluR Vertebrates 380 Cation conductance Depolarization of Vm Volgraf et al. (2006);
Li et al. (2012)
chARGe D. melanogaster 430-550 PLC-mediated cation
conductance
Depolarization of Vm Zemelman et al. (2002)
NpHR
(halorhodopsin)
N. pharaonis 570 Chloride conductance Hyperpolarization of Vm Zhang et al. (2007)
Opto-α1AR Chimeric B.
primigenious and H.
sapiens
504 IP3, DAG generation Gq/PLC signaling pathway Airan et al. (2009)
Opto-β2AR Chimeric B.
primigenious and M.
auratus
504 cAMP generation Gs/AC signaling pathway Airan et al. (2009)
Here we list optogenetic actuators that have been developed from different source organisms, with efforts made to vary the absorption spectra, emission spectra,
and target function. Vm, membrane potential; NDBF, Nitrodibenzofuran; IP3, Inositol 1,4,5-triphosphate; DAG, diacylglycerol; cAMP, cyclic adenosine monophosphate;
Gq/PLC, phospholipase-C; Gs/AC, adenylyl cyclase; ROS, reactive oxygen species; α1AR, alpha-1 adrenergic receptor; β2AR, beta-2 adrenergic receptor.
with appropriate tropic bias or by pseudotyping – repackaging the
genetic material of one virus in the protein capsid of another to
produce a combination viral particle that will readily prefer to
infect a researcher’s target cell type (Wang et al., 2011). Further-
more, spatial targeting of viral transfection may be achieved by
stereotaxic injection and post-hoc conﬁrmation. Importantly, the
location of genomic integration of virally delivered genes may
be random, and unwanted mutagenic effects or unexpected gene
silencing can hinder this approach. In zebraﬁsh, this non-speciﬁc
effect can be avoided with transgene expression using injec-
tion of plasmid vectors (Faucherre et al., 2009), and can include
genomic integration using meganuclease-mediated gene insertion
(Grabher et al., 2004) or tol2 recombination (Suster et al., 2009).
Stable transgenics, where the transgene is integrated into the
host’s germline, offers several advantages including the ability
to repeat experiments across animals or ensure comparability
between experiments ondifferent organ systems andbrain regions.
In addition, if non-targeted gene insertion will cause unwanted
effects, researchers can target transgene insertion through tech-
niques including homologous recombination (von Koch et al.,
1997). This may help to minimize transgene silencing or muta-
genic effects due to insertion locus. Also, stable integrated
transgenic organisms may show greater homogeneity of expres-
sion levels across tissues and animals, and comparisons can be
made between different developmental time points. In order to
exploit the expression pattern of a well-characterized promoter,
homologous recombination can be used to insert a gene down-
stream of an endogenous promoter, or the inserted sequence may
itself contain a promoter region.
MODULAR TRANSGENICS FOR OPTOPHYSIOLOGY
For optophysiology with genetically encoded proteins, speciﬁc
over-expression is generally very important. This is both for
ensuring adequate activation when using photoactuators, and for
increasing the signal-to-noise ratio of experiments with photosen-
sors. Several modular transgene systems have been developed to
facilitate cell-type speciﬁcity and strong expression. The double-
ﬂoxed inverse open reading frame (DIO) strategy devised by Karl
Deisseroth’s group provides one such method for minimizing so
called “transcriptional leakage” while simultaneously achieving
high expression levels (Figure 1; Sohal et al., 2009). This strategy
improves on a common two-part scheme for transgene expression,
wherein a promoter with high cell-speciﬁcity drives the expression
of Cre recombinase, while a promoter with stronger expression
drives a desired transgene with a ﬂoxed stop codon. In this tradi-
tional formulation of the ﬂoxed-stop scheme, the researcher can
combine the spatiotemporal speciﬁcity of the ﬁrst promoter with
the transcriptional strength of the second. Excision of the stop
codon and subsequent expression of the transgene will ideally
occur only following Cre expression at the appropriate develop-
mental time point or within cells of interest. Practically speaking,
though, there can be transcriptional leakage when the stop codon
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FIGURE 1 | Diagram of DIO transgenic system in mice.The double-
ﬂoxed inverse open reading frame (DIO) construct comprises inverted
terminal repeats (ITR), the EF1α promoter, an eYFP-ChR2 fusion gene
surrounded by a pair of LoxP sites and a pair of Lox2722 sites oriented
inward, a woodchuck hepatitis virus post-transcriptional regulatory element
(WPRE) and a human growth hormone polyadenylation signal (hGH polyA).
The eYFP-ChR2 gene starts in an inverted, inactive orientation. Expression
of Cre recombinase will cause serial recombination resulting in the active,
ﬁxed orientation of the transgene (bottom; ﬁgure adapted from Sohal et al.,
2009).
fails to completely prevent transcription of the transgene. This can
be particularly detrimental in the case of a high-expression pro-
moter that is generally ubiquitously expressed and constitutively
active. The innovation of Sohal et al.’s (2009) modiﬁcation is that
the transgene is initially inverted and truly inactive in its “off”
state. Expression is accomplished using two pairs of incompatible
lox sites that ﬂank the inverted transgene. Serial recombination
will ﬁrst reorient the transgene and then excise one of the two lox
sites from each pair, and the ﬁnal state of the gene contains only
an incompatible pair of lox sites that are no longer responsive to
Cre. This reorientation mechanism can be used as a Cre-on sys-
tem where the initial orientation of the gene is inactive, or Cre-off
where the initial orientation of the gene is active. To add even
more degrees of control, this mechanism can be used as a Cre-
switch system if the double-ﬂoxed region contains two genes in
opposite orientations with a stop codon between, though tran-
scriptional leakage of the stop codon again becomes a factor in
this setup (Saunders et al., 2012).
Another method for creating modular transgenics was devel-
oped by Tanaka et al. (2012). Called the KENGE-tet system (short
for knock-in mediated enhanced gene expression) this system is
based on the tetracycline transactivator-responsive TetO promoter
and is comprised of two parts, the transgenic protein of interest
(e.g., ChR2) and a tetracycline transactivator gene (Tanaka et al.,
2012). Like theDIO strategy, this approach allows the researcher to
separately control several aspects of expression pattern. The pro-
moter driving the gene coding for the tetracycline transactivator
(tTA)determines the tissue speciﬁcity of gene expression,while the
expression intensity and timing are controlled by the exogenous
administration of tetracycline to either trigger (Tet-on) or silence
(Tet-off) expression of the transactivator. To prevent unwanted
chromosomal silencing or suppression effects, Tanaka et al. (2012)
chose to insert the transgene driven by the TetO promoter adja-
cent to the beta-actin gene, known for its ubiquitous high-level
expression.
These two modular expression systems offer a variety of scal-
able expression patterns in transgenic animals. New combinatorial
possibilities can be created by crossing existing driver lines of tTA
or Cre animals with new transgenic protein lines, or vice versa.
This also enables one to exploit the many databases of driver
lines such as the GENSAT project, which pre-compile driver lines
with physiologically interesting expression patterns (e.g., Geffers
et al., 2012). Often such databases of driver lines are constructed
using an enhancer trap screen. In this approach, a large number of
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transgenic animals are generated through random insertion of a
marker gene. The resulting expression patterns of the marker gene
are screened, allowing the researcher to select a pattern appropri-
ate for the cell population or for the developmental time course
they aim tomodify (Asakawa andKawakami,2009). By sequencing
the genomic DNA upstream or downstream from the integrated
marker, the researcher can identify the genetic region that is likely
to be driving a particular expression pattern. Thus, an organism
with an interesting expression pattern can be subsequently used to
obtain a desired promoter or enhancer for driving a transgene of
interest (see, for example, Pujol-Martí et al., 2012). This technique
lends itself well to use with the Gal4/UAS transcriptional system
(Scott et al., 2007; Asakawa and Kawakami, 2009). Here, the Gal4
gene product activates transcription of a transgene located after
the cognate upstream activator sequence (UAS), which conﬁnes
expression to the area of tissue-speciﬁc GAL4 expression. Thus, by
generatingmanyGAL4 driver lines and a library of UAS-transgene
lines, offspring with a desired transgenic expression pattern can be
produced by the proper mating combination.
Another approach to improving population-selective expres-
sion of transgenes is repression of transcription in undesired
tissues. The transcription factor REST is expressed in non-
neuronal tissues and has been shown to repress inappropriate
transcription of neuronal genes by binding to a DNA motif
called the neuron-restrictive silencing element (NRSE; Mandel
et al., 2011). In order to probe the circuit function of neurons
by ablation, Bergeron et al. (2012) developed a derivative silenc-
ing element called REx2. They validated and quantiﬁed the effect
of this silencing element by showing that restriction is relaxed by
the introduction of a morpholino (a small oligonucleotide that
blocks translation of an mRNA target) against the REST gene.
Importantly, this silencing motif can be used in conjunction with
existing promoter regions derived from enhancer trap screens to
further improve speciﬁcity. The authors show the impact of their
silencing element particularly in the context of ablation experi-
ments, though it also has broad applicability to marker genes or
other functionally diverse transgenes (Bergeron et al., 2012). In
summary, there are many approaches available for expression of
genetically encoded photosensors and photoactuators. It is nowup
to the optophysiologist to determine themost appropriatemethod
for their desired experiment and animal model system.
OPTICS HARDWARE AND SOFTWARE
Development and adaptation of optics technology is a key com-
ponent for progress in optophysiology. Moving from excitation
of ﬂuorophores using wide-ﬁeld illumination to true cell-speciﬁc
excitation has required not only advances in transgene expression
targeting, but also strategic application of knowledge from ﬁelds
including optics and multi-photon laser microscopy.
For spatial targeting the activation of photoactuators, one
approach is the use of digitalmicro-mirror devices (DMDs). These
devices produce a variable spatial light pattern with a resolution
limit set by the surface pixilation of a given DMD. The DMD
operates by changing the angle of reﬂection in areas correspond-
ing to the desired “dark” regions on a sample such that the beam
path from these points will not reach the target. In this way, they
are subtractive, meaning that there will necessarily be a loss of
stimulation power when the DMD is in use, which may require a
compensatory increase in the initial light power (Oron et al., 2012).
Another approach for targeting excitation of a photoactuator
involves theuse of spatial lightmodulators (SLMs;Nikolenko et al.,
2008; Oron et al., 2012; Prakash et al., 2012). SLMs are an instance
of digital holography, a technique that uses phase-modifying ﬁl-
ters to produce a cross-sectional pattern of phase relationships.
This pattern of transmitted light, when focused onto the plane
of interest, will undergo constructive interference where activa-
tion is desired and destructive interference where activation is not
desired. The technique allows a researcher to avoid regions of
overlap with non-target cells and thereby maintain cell-speciﬁc
activation. Packer et al. demonstrated the possibility of using this
technique to achieve a three-dimensional pattern of activation
by simultaneously but independently stimulating cells in differ-
ent focal planes (Packer et al., 2012). This technique is still under
development, and there currently remain limits on the degree of
spatial ﬂexibility afforded by SLMs.
Recently, Kim et al. (2013) described a new cellular-scale opto-
electronic implant that allows remote control of cellular activity in
freely moving animals. Such advancements in optics technology
open up the potential to explore the role of circuit elements in an
awake behaving animal.
The technology necessary for optical recording differs from
the technology necessary for optical activation. For some applica-
tions, wide-ﬁeld light may be sufﬁcient for imaging photosensor
responses. Here, the emphasis would shift to designing cameras
and software of sufﬁcient speed and resolution to detect events
that may occur up to the kilohertz range and also to detect faint
signals in an optically noisy environment (Rózsa et al., 2007). For
in vivo systems or for achieving greater light penetration, stim-
ulation through ﬁber optic cables may be preferable (Ung and
Arenkiel, 2012). Some research groups have begun using even
more sophisticated approaches. Ahrens et al. (2013) recently made
dramatic progress in scaling up optics technology for use with
physiological systems, designing a system capable of imaging 80%
of neurons in a larval zebraﬁsh brain in vivo at 0.8 Hz. Their tech-
nique used scanning light-sheet ﬂuorescence microscopy with a
GCaMPphotosensor protein. In achieving such large-scale activity
measurements, they have provided a crucial proof of concept for
the future of whole-brain research, and demonstrated the poten-
tial of currently existing protein photosensors and photoactuators
(Ahrens et al., 2013).
Inevitably, the limits of currently available optics equipment
will have to be addressed by the use of software for tasks like
interpolation between time-series measurements when image
acquisition speed is insufﬁcient, or screening out unrelated activ-
ity when background noise is high. Development of this software
is as important for making meaningful conclusions as the tech-
nology necessary for data collection. Key issues to be addressed
by any software system include noise ﬁltration, image alignment
(especially for ratiometric and time lapse imaging), compensation
for movement artifacts, deﬁning discrete signals and assigning
those signals to a source cell, and statistical analysis of signals
to draw meaningful conclusions. Cutting-edge video processing
techniques may facilitate data acquisition. For instance, a group
at MIT’s CSAIL recently published open-source code for Eulerian
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Video Magniﬁcation that greatly ampliﬁes small visual signals for
easier detection (Wu et al., 2012).
PHYSIOLOGICAL APPLICATIONS
BEHAVIOR
Optophysiology has been applied to a diverse range of animal
models in order to elicit behavioral responses. The conclusions
that have been drawn vary as much as the experimental model and
question. In 2005, Lima and Miesenböck expressed ligand-gated
ionotropic P2X purinoreceptor in giant ﬁber neurons implicated
in escape reﬂex initiation in the fruit ﬂy. This study showed that
decapitated ﬂies still had normal escape responses to giant ﬁber
activation by photo-uncaging a modiﬁed version of ATP (Lima
and Miesenböck, 2005). This early and dramatic demonstration
of behavioral control through optical activation of neurons was
an important proof of concept for the ﬁeld. Leifer et al. provided
sharp contrast for the pace of progress in 2011 with the develop-
ment of a systemcalledCoLBeRT capable of delivering stimulation
pulses at 50 Hz with a spatial resolution of 30 μm. Using this tech-
nique, they interacted with muscle cells and touch receptor cells
to manipulate the movements of a freely swimming worm (Leifer
et al., 2011).
Witten et al. (2010) investigated the role of cholinergic
interneurons in the nucleus accumbens (NAc) using AAV vector
delivery of Cre recombinase-dependent eNpHR3.0. Despite the
low proportion of these interneurons in the NAc, the researchers
found that inhibition of their activity by photo-activation of
eNpHR3.0 during a cocaine place-conditioning paradigm caused
a signiﬁcant decrease in acquired, conditioned place preference
(Witten et al., 2010). In contrast to previous ideas about NAc cir-
cuit composition, these results indicated that the NAc cholinergic
cells are important to reward based learning. Importantly, this
study also showed the power of optophysiology for behavioral
studies.
More recently, Liu et al. (2012) investigated the network cor-
relate of a memory within the dentate gyrus circuitry of the
hippocampus in mice. Using a novel technique for cell activity-
dependent expression of ChR2, the authors attempted to induce
recall of a fear memory using photo-activation. They used an
AAV vector to transfect ChR2 under the control of a tetracycline
response element promoter (tetO:ChR2) into mice carrying the
tetracycline transactivator gene under the control of a c-Fos pro-
moter (c-Fos:tTa). This arrangement allowed the researchers to
externally suppress ChR2 expression, and then selectively allow
expression during the presentation of a novel fear stimulus. The
idea was that transcription of the immediate early gene, c-Fos
would occur only in active cells of the hippocampus during
presentation of the fear stimulus, which would then lead to trans-
activation of the ChR2 gene. Subsequently, the researchers showed
that photo-activation of the ChR2-expressing population of cells
resulted in freezing behavior of the mouse – indicative of fear
memory recall. In addition, activation of ChR2 in cells active
during presentation of non-fearful stimuli did not cause freezing
behavior during photo-stimulation. This extremely novel result
has important ramiﬁcations for the understanding of memory
encoding, and raises ideas for many future studies on the role of
such hippocampal “engrams” (Liu et al., 2012).
Studies from primate model systems are also invaluable for
our understanding of human neurophysiology and for looking
toward future clinical applications of optophysiology. Jazayeri et al.
(2012) investigated vision and saccadic eye movements in rhesus
monkeys, seeking to achieve optogenetic control of complicated
primate behavior where past studies had encountered difﬁculties.
Rhesus monkeys naturally orient their vision toward ﬂashed stim-
uli. Thus, the researchers transfected areas of visual cortex (V1)
with ChR2 using an AAV vector in an attempt to induce photo-
controlled saccades. They found that photo-stimulation of the
transfected region induced a large proportion of saccades in the
direction corresponding to the receptive ﬁeld of the region. They
speculated that their success at inducing this visuomotor activity
was due to the choice of V1 as the stimulation target (Jazayeri et al.,
2012). While V1 circuitry may be primed to respond to unknown
stimulation patterns, visuomotor areas may require speciﬁc pat-
terns of input that studies using wide-ﬁeld light activation are
unable to deliver.
NEURAL CIRCUITS AND NETWORKS
Here, we present several studies that highlight the potential of
optophysiological studies on the function of neural networks and
pathways. Sohal et al. (2009) developed the DIO strategy dis-
cussed above with an AAV vector to transfect various mouse
cortical neuronal populations with ChR2 or eNpHR to study
the role of parvalbumin (PV)-positive cortical interneurons in
gamma-frequency oscillations of brain activity. They noted that
past studies had suggested gamma-frequency activity may play
a neuromodulatory role in information processing in the cor-
tex. Interestingly, they found that inhibiting PV interneurons
decreased,while stimulating cortical pyramidal neurons increased,
the power of gamma-frequency oscillations in vivo (Sohal et al.,
2009). The authors also showed that driving PV interneurons in
vitro in brain slices increased the observed gamma-frequency oscil-
lations in the preparation. Electroencephalography (EEG) studies
have attempted to identify behaviors that are commonly associ-
ated with activity in speciﬁc frequency bands (Lutz et al., 2004).
By drawing a link between a cell type and a previously extensively
characterized oscillatory mode, the research helps to increase the
relevance of EEG studies to behavior and disease.
Subsequent to this study, Piña-Crespo et al. (2012) produced
embryonic stem-cell derived neurons, transfected them with
ChR2 and NpHR, and transplanted them into cultured hip-
pocampal slices. Using electrophysiology measurements with a
multi-electrode array, they showed that light activation of the
transplanted neurons could induce high-frequency oscillatory
activity in vivo (Piña-Crespo et al., 2012). The researchers spec-
ulated on the therapeutic potential of such a transplant in an
individual with disruptions in this oscillatory activity. Further-
more, this study demonstrates the effectiveness of combining
electrophysiology with optophysiology.
POTENTIAL CLINICAL APPLICATIONS
MOVEMENT DISORDERS
Movement disorders of the basal ganglia pathway are numerous
and complex, and none yet have a completely deﬁned pathophysi-
ology. The continuing trend of experiments seeking to explore this
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circuitry and its deﬁcits during disease through targeted optophys-
iology manipulation may provide insight into both the neurotypic
and pathologic brain. Indeed, several studies have already shown
that optogenetic intervention can restore normal motor function
in animal models of nigrostriatal degeneration (Gradinaru et al.,
2009; Kravitz et al., 2010; Peppe et al., 2012).
One example comes from the research of Gradinaru et al.
(2009),who sought to understand the reason that deep-brain stim-
ulation (DBS) of the sub-thalamic nucleus (STN) can be beneﬁcial
for symptoms of Parkinson’s disease. The authors found that nei-
ther NpHR-mediated inhibition nor ChR2-mediated excitation of
the STN produced an improvement of behavioral symptoms in
rats with lesions to the nigrostriatal pathway. Interestingly, they
did ﬁnd that high-frequency ChR2-mediated stimulation of the
afferent ﬁbers to the STN produced a dramatic and reversible
improvement of Parkinsonian symptoms, a result with clinical
relevance that may guide the targeting of future DBS surgeries and
other efforts at reducing symptoms.
Another study by Kravitz et al. (2010) also looked at basal gan-
glia pathways in Parkinson’s disease, but focused on different
components of the pathway. They used an AAV vector to selec-
tively transfect DIO ChR2 into mice expressing Cre recombinase
in select populations of basal ganglia neurons. In thismanner, they
produced selective expression of the light-gated channel in only
“direct” or “indirect” motor neuron pathways. They then showed
that selective activation of indirect pathway neurons in the basal
ganglia produced Parkinsonian-like motor behavior, while acti-
vation of direct pathway neurons produced the opposite effect.
This result supported past theories about the roles of these two
neuronal populations in motor control and Parkinson’s disease
(Kravitz et al., 2010). Furthermore, they showed that selective
transfection and activation of direct pathway neurons reversibly
restored all motor deﬁcits in a mouse model of Parkinson’s dis-
ease. Their results provide powerful support for the current model
of Parkinson’s-induced basal ganglia degeneration and suggest a
future of optogenetic DBS therapy with potentially better target
speciﬁcity than current treatment efforts (Peppe et al., 2012).
Other optophysiological studies of movement disorders have
focused on cell-replacement techniques. Tønnesen et al. (2011)
investigated the integration and subsequent functional state of
stem cell-derived neural grafts with ChR2 and NpHR into striatal
slices from a mouse model of Parkinson’s disease. The researchers
used optical stimulation and inhibition of these transplanted neu-
rons to show that the cells were capable of exhibiting normal
synaptic activity. Their results support an exciting potential for
application of optophysiology studies to uncover therapies for
treatment of human Parkinson’s disease symptoms.
SEIZURES AND EPILEPSY
Optically responsive protein tools may ﬁnd important usage in the
treatmentof seizures and epilepsy. Current therapeutic approaches
often rely on the use of broad-acting drugs or non-speciﬁc
closed-loop electrical intervention, whereas an optophysiological
treatment could have reduced peripheral side effects. A number of
studies on varied animal models of epilepsy have already shown
the potential of this research avenue (Bentley et al., 2013; Kokaia
et al., 2013).
In their investigation of the cause of epilepsy subsequent to cor-
tical trauma, Paz et al. (2013) found that inducing cortical stroke
in rats leads to increased excitability of thalamocortical projec-
tions, as well as epileptiform activity in the thalamus. To probe the
importance of these neurons in the observed epileptic phenotype,
they stereotaxically injected an AAV vector containing eNpHR3.0
under the control of the CamK2a promoter, and found that inhi-
bition of these thalamic neurons during a seizure can interrupt
an ongoing seizure (Paz et al., 2013). Similarly, Sukhotinsky et al.
(2013) studied the role of hippocampal pyramidal neurons in a
rat lithium–pilocarpine model of epilepsy. Like Paz et al. (2013),
they also used stereotaxic injection of an AAV vector containing
eNpHR3.0 under the control of CamK2a promoter. They found
that inhibition of the targeted hippocampal neurons caused a
modest delay in the onset of status epilepticus. They noted that
their single hemisphere experiment may have limited the effec-
tiveness of their treatment, and that a dual hemisphere approach
may have greater success (Sukhotinsky et al., 2013). These results
support the exploration of regional inhibition in the prevention
of epileptic seizures.
Only very recently have researchers explored the possibility
of using optogenetic excitation of inhibitory interneurons as a
method of blocking epileptiform activity. Krook-Magnuson et al.
(2013) studied a mouse model of temporal lobe epilepsy (TLE)
produced by unilateral dorsal hippocampal injections of kainate.
They note that TLE provides an appealing target for therapeu-
tic intervention because the onset of global epileptiform activity
is generally preceded by a period of localized abnormal activ-
ity. In this way, there is an opportunity for the development
of a closed-loop device – a device which detects and disrupts
abnormal activity during the development of a seizure. The
researchers used CamK2a:Cre to drive NpHR expression in exci-
tatory neurons, or Parvalbumin:Cre to drive ChR2 expression
in inhibitory neurons. They found that inhibition of excitatory
neurons in the hemisphere ipsilateral to the kainate injection
signiﬁcantly interrupted seizures. Importantly, they found that
excitation of inhibitory neurons using ChR2 on either the ipsilat-
eral or the contralateral hemisphere also signiﬁcantly interrupted
seizures (Krook-Magnuson et al., 2013). Altogether, this impor-
tant research provides strong support for the use of optogenetics
in the treatment of seizures and epilepsy.
VISION DISORDERS
Diseases of vision are also a potential area for clinical applica-
tion of optophysiology. Indeed, this may be a natural application
of optogenetic tools, as many of these proteins used originated
in visual systems. Retinitis pigmentosa (RP) is a genetic disease
that causes sequential dysfunction of rod and cone photoreceptor
cells, leaving afﬂicted patients with intact but inactive cone cells.
Busskamp et al. (2010) demonstrated the potential for functional
recovery through optogenetic intervention by transfecting inac-
tive cone cells with eNpHR3.0 using an AAV vector in a mouse
model of RP. Since light normally hyperpolarizes photoreceptors
in vertebrates, the authors could induce behavioral responses by
triggering hyperpolarization of the transgenic cells, showing that
some of the connectivity necessary for normal function remains
after the cells become inactive. They also applied this technique to
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ex vivo human retinal tissue and successfully induced photocur-
rents. More recently, expression of ChR2 inmouse retinal ganglion
cells combined with advanced retinal prosthetics has produced
remarkable results on restoring vision in blind mice (Nirenberg
and Pandarinath, 2012).
HIGH-THROUGHPUT EX VIVO Studies
All-optical manipulation and measurement of cultured tissue may
also hold promise as a high-throughput drug screening plat-
form. One of the fastest growing areas of current clinical research
is the creation of systems which may provide an informative
model of neurodevelopmental disorders such as autism spec-
trum disorders (ASDs) or neurodegenerative disorders such as
amyotrophic lateral sclerosis (ALS). The inaccessibility of ner-
vous tissue from persons with neurogenetic disorders has been
a long-standing obstacle for the study of these diseases. Recent
advances in transcriptomic analysis suggest that expression data
will be very valuable in characterizing disease states and evaluating
potential therapeutics (Schmid et al., 2012). However, optophysi-
ology can provide a direct, scalable cellular phenotype in addition
to other readouts. The Cohen Lab at Harvard has demonstrated
the capability to screen anti-arrhythmogenic drugs on induced
pluripotent stem cell-derived cardiomyocytes (Adam Cohen, per-
sonal communication). They recently demonstrated the ability
to discriminate drugs with pre-deﬁned toxicity through optical
measurements of drug-induced changes in conduction charac-
teristics of cardiac action potentials. This model for an ex vitro
drug-screening platform is appealing for its scalability and relative
simplicity; much of the analysis can be automated by software,
and the results are both reproducible and directly applicable to
high-throughput drug evaluation.
POTENTIAL TOOLS FOR THE OPTOPHYSIOLOGY TOOLBOX
While there are many optogenetic photoactuators and genetically
encoded photosensors available, the search is still on for proteins
that will allow greater temporal control and readout of a neu-
ron’s activity. One exciting possibility for a fast voltage sensor
could come from Tuberous electroreceptor cells. Weakly elec-
tric ﬁsh in the orders Gymnotiformes and Mormyriformes detect
and encode changes in a projected electric ﬁeld, including ampli-
tude and frequency variation. These animals are sensitive to phase
modulations of their own projected ﬁeld as small as 100–300 ns,
indicating an extremely high sensitivity in the frequency domain.
If this sensitivity can be attributed to a sensory transduction pro-
tein, then there may be a possibility for coupling that protein’s
voltage response to a ﬂuorophore to produce a high frequency
voltage probe (Kawasaki, 2009; Fortune and Chacron, 2011).
Another area for improvement results from the current spectral
overlap of many of the current optophysiological tools. Many of
the proteins engineered for photo sensing and actuation are based
on the transduction mechanism of retinal pigments. This has
been beneﬁcial due to the well-characterized photocycle of opsins
and the wide number of species from which they can be derived.
However, another class of photosensitive proteins, called tran-
sient receptor potential (TRP) proteins has largely been unused in
optophysiology. These TRP channelsmay have a unique and favor-
able set of properties as the basis for both sensors and actuators.
Many subfamilies are sensitive to photons in infrared wavelengths,
and function as the basis of thermoreceptive pit organs in rep-
tiles, vision in some insects, and skin thermoreception in some
mammals (Gracheva et al., 2010). Their distinctly shifted absorp-
tion spectra and different phototransduction mechanism may
make them useful for increasing the variety of tools available for
optophysiology.
CONCLUSION
The cell- and tissue-speciﬁc expression of transgenic proteins
and the tremendous library of past electrophysiology research
decoding cellular events and activity has set the stage to address
large, integrative questions on topics such as memory, emotion,
attention and consciousness. Current optophysiological research
continues to advance these questions and improve the technologies
necessary to support the use of genetically encoded photosensors
and optogenetic photoactuators, often concurrently (e.g., Aker-
boom et al., 2013). Innovations include the optics necessary for
light-stimulation and recording, the software necessary for anal-
ysis of data produced, and the gene delivery methods necessary
for spatiotemporal control of expression of transgenic proteins.
Due to the rapid development of the ﬁeld and the numerous
opportunities for improvement of each component, optophysiol-
ogy represents an excitingﬁeld of neurosciencewith great potential
for basic science and clinical research.
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